EVENT 2021

CANCER CROSSLINKS 2021 - A Digital Event

THEME:
Driving the Translation of Scientific Insights Into Clinical Practice:
From "Nice to Know" to "Need to Implement"

The 13th Cancer Crosslinks was presented on

Thursday, January 21, 2021

This engaging event gathered a distinguished panel of international experts who presented recent progress in precision treatment and cancer immunotherapy. An overview of the speakers, topic titles, moderators, panelists, and the program are highlighted on this page.

Event 2021 - International Speakers

Ahmad Awada, Professor, Head of the Oncology Medicine Dept., Jules Bordet Cancer Institute Brussels, Belgium

Jérôme Galon, Director of Research at INSERM, Head of INSERM laboratory for Integrative Cancer Immunology, Cordeliers Research Center, Paris, France

Marcela Maus, Assistant Professor, Medicine, Harvard Medical School,
Director of Cellular Immunotherapy, Cancer Center, Massachusetts General Hospital, USA

Andrew Sewell, Professor, Division of Infection and Immunity. Mechanisms of Immunity Theme Lead, Systems Immunity Research Institute, Cardiff University, UK

Emile Voest, Professor of Medical Oncology, Medical Director of The Netherlands Cancer Institute, NL

Event 2021 - Topics

Utilizing Targeted Therapy and Immunotherapy Earlier: What is the Rationale and How Cancer Patients Benefit. Ahmad Awada, Jules Bordet Cancer Institute Brussels, Belgium

The Interplay between Tumor Evolution and Tumor Immunology: Implications on Progression and Treatment. Jérôme Galon, Cordeliers Research Center, Paris, France

Translating Next Generation Cell Therapies into the Clinic: What are Hurdles and How Can We Overcome These? Marcela Maus, Harvard Medical School, Massachusetts General Hospital

New T-cell Receptors and Targets by Dissection of Successful Cancer Immunotherapy. Andrew Sewell, Cardiff University, UK

Bringing Precision Medicine to Patients: Lessons Learned from DRUP Trial and the Way Forward.
Emile Voest, The Netherlands Cancer Institute

Event 2021 - Moderators & Panelists from Norway

Moderator, Session 1:
Jon Amund Kyte, Head, Department of Experimental Cancer Treatment, Oslo University Hospital Comprehensive Cancer Center, Oslo
Panelists, Session 1:
Halfdan Sørbye, Professor, Department of Oncology, Haukeland University Hospital, Bergen
Anne Hansen Ree, Professor of Oncology, Akershus University Hospital, University of Oslo
Nina Jebsen, Associate Professor, Dept. of Clinical Science, Haukeland University Hospital, Bergen
Emiel A.M. Janssen, Professor, University of Stavanger, Dept. of Pathology, Stavanger University Hospital, Stavanger

Moderator, Session 2:
Johanna Olweus, Professor, University of Oslo, Head of Department of Cancer Immunology, Oslo University Hospital
Panelists, Session 2:
Jochen Buechner, Senior Consultant Pediatric Hematology & Oncology, Oslo University Hospital
Ingerid Weum Abrahamsen, Senior Consultant Hematology, Department of Hematology, Oslo University Hospital

Moderator, Session 3:
Sigrid Bratlie, Special Advisor, Norwegian Cancer Society
Panelists, Session 3:
Åslaug Helland, Professor, Head of Research Division of Cancer Medicine, Oslo University Hospital
Ali Areffard, Disease Area Specialist Immuno-Oncology, Bristol Myers Squibb
Siri Børø, Medical Specialist Oncology, Merck

Event 2021 - Reference Materials

The Event Guide (includes program) may be downloaded HERE.
The Program may be downloaded HERE.
The Recorded Sessions are no longer available. Note: Access was available from January 21 to February 21, 2021 (if you registered for the event). We look forward to presenting Cancer Crosslinks in January 2022. Information and updates will be posted on this website. Thank you for your interest.

Organizer

Sponsors 2021

To learn more about previous Cancer Crosslinks events, visit the GALLERY.